Janney Montgomery Scott LLC Global Blood Therapeutics, Inc. Transaction History

Janney Montgomery Scott LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 06, 2020	SELL	$52.76 - $74.49 $298,990 - $422,134	-5,667 Closed	0 $0
Q2 2020 Jul 23, 2020	SELL	$48.73 - $81.82 $94,926 - $159,385	-1,948 Reduced 25.58%	5,667 $358,000
Q1 2020 Apr 30, 2020	BUY	$41.72 - $87.2 $37,548 - $78,480	900 Added 13.4%	7,615 $389,000
Q4 2019 Jan 21, 2020	SELL	$45.7 - $81.86 $28,562 - $51,162	-625 Reduced 8.51%	6,715 $534,000
Q3 2019 Oct 29, 2019	SELL	$45.35 - $57.91 $11,337 - $14,477	-250 Reduced 3.29%	7,340 $356,000
Q2 2019 Jul 29, 2019	BUY	$52.6 - $63.29 $143,861 - $173,098	2,735 Added 56.33%	7,590 $399,000
Q1 2019 Apr 30, 2019	BUY	$39.99 - $53.48 $194,151 - $259,645	4,855 New	4,855 $257,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

Stay updated on Janney Montgomery Scott LLC with notifications on news.